Clinical Trial Update: Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from Vanderbilt University Medical Center examining cholinergic integrity in individuals with Down syndrome to explore aging, Alzh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Down Syndrome, Down Syndrome, Partial Trisomy 21 | Phase 2 | Status: ACTIVE_NOT_RECRUITING